methylprednisolone has been researched along with Clerambault Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Akçay, N; Bektaş, G; Boydağ, K; Şevketoğlu, E | 1 |
| Atallah, AN; Castro, AA; Fernandes Moça Trevisani, V; Ferreira Neves Neto, J | 1 |
| Lau, TC; Lim, AY; Santosa, A; Teng, GG; Vasoo, S | 1 |
| Cuypers, L; Esseveld, MM; Schieveld, JN; van de Riet, EH | 1 |
| Albaladejo Devis, I; Cubillana Herrero, JD; Jiménez Cervantes-Nicolás, JA; Minguez Merlos, N; Rodríguez González-Herrero, B; Soler Valcárcel, A | 1 |
| Atallah, AN; Castro, AA; Neves Neto, JF; Trevisani, VF | 2 |
| Otto, V | 1 |
| Kuroki, M; Okano, R; Otsuka, M; Ueki, A; Yamada, A | 1 |
| Benazzi, F | 1 |
| Fleischhacker, WW; Klein, G; Unterweger, B | 1 |
| Hirai, K; Hirohata, S; Matsuo, H; Miwa, A; Miyamoto, T; Suzuki, S; Tsurui, H | 1 |
| Beacham, B; Klestov, A; Price, J; Roberts, C | 1 |
| Colenda, CC; Gaston, JO | 1 |
4 review(s) available for methylprednisolone and Clerambault Syndrome
| Article | Year |
|---|---|
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
Topics: Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Neurocognitive Disorders; Neuroprotective Agents; Randomized Controlled Trials as Topic; Seizures | 2013 |
[Susac syndrome as a cause of sensorineural hearing loss].
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Cerebral Infarction; Cochlea; Combined Modality Therapy; Deafness; Diagnosis, Differential; Female; Fever; Hallucinations; Hearing Loss, Sensorineural; Humans; Hyperbaric Oxygenation; Infarction; Magnetic Resonance Imaging; Methylprednisolone; Microcirculation; Neurocognitive Disorders; Nimodipine; Platelet Aggregation Inhibitors; Retinal Vessels; Syndrome; Vision Disorders | 2002 |
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
Topics: Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Neurocognitive Disorders; Neuroprotective Agents; Seizures | 2006 |
Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus.
Topics: Antirheumatic Agents; Cranial Nerve Diseases; Cyclophosphamide; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Neurocognitive Disorders; Neuroprotective Agents; Seizures | 2000 |
10 other study(ies) available for methylprednisolone and Clerambault Syndrome
| Article | Year |
|---|---|
Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children.
Topics: Brain Diseases; Child; Corpus Callosum; COVID-19; COVID-19 Drug Treatment; Dyspnea; Electroencephalography; Exanthema; Female; Fever; Glucocorticoids; Hallucinations; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Magnetic Resonance Imaging; Male; Methylprednisolone; Neurocognitive Disorders; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Tachypnea | 2021 |
Neurosjögren: early therapy is associated with successful outcomes.
Topics: Adult; Aged; Blood Sedimentation; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Nervous System Diseases; Neurocognitive Disorders; Pulse Therapy, Drug; Retrospective Studies; Sjogren's Syndrome; Time-to-Treatment | 2012 |
Drawings during neuropsychiatric recovery from anti-NMDA receptor encephalitis.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Art Therapy; Autoimmune Diseases of the Nervous System; Cognition Disorders; Drug Therapy, Combination; Encephalitis; Female; Humans; Immunization, Passive; Mental Status Schedule; Methylprednisolone; Neurocognitive Disorders; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Rituximab | 2013 |
[Neurologic complications in hypereosinophilia syndrome--a case report].
Topics: Adult; Aphasia; Cerebral Infarction; Cyclophosphamide; Dose-Response Relationship, Drug; Eosinophils; Humans; Hypereosinophilic Syndrome; Leukocyte Count; Male; Methylprednisolone; Neurocognitive Disorders; Neurologic Examination | 1993 |
[Leptomeningeal abnormality on Gd-DTPA enhanced MRI in a case of SLE presenting diffuse organic brain syndrome].
Topics: Adult; Arachnoid; Female; Gadolinium DTPA; Humans; Image Enhancement; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Neurocognitive Disorders; Organometallic Compounds; Pentetic Acid; Pia Mater | 1993 |
Resistant depression associated with lupus erythematosus and steroid therapy.
Topics: Aged; Antidepressive Agents; Dementia, Multi-Infarct; Depressive Disorder; Diagnosis, Differential; Drug Resistance; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Neurocognitive Disorders; Psychoses, Substance-Induced | 1997 |
Plasma exchange for cerebral lupus erythematosus.
Topics: Adolescent; Combined Modality Therapy; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Neurocognitive Disorders; Plasma Exchange | 1988 |
[Complete recovery from severe organic brain damage in a patient with systemic lupus erythematosus].
Topics: Adolescent; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Mutism; Neurocognitive Disorders; Prednisolone | 1987 |
A case of cerebral systemic lupus erythematosus treated with methylprednisolone pulse therapy.
Topics: Adult; Brain Diseases; Female; Humans; Injections, Intravenous; Lupus Erythematosus, Systemic; Methylprednisolone; Neurocognitive Disorders | 1985 |
Psychogenic unresponsiveness in a patient with lupus cerebritis.
Topics: Adult; Azathioprine; Coma; Drug Therapy, Combination; Encephalitis; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Neurocognitive Disorders | 1986 |